Table 8.
Diagnostic criteria for psychotic disorders and exclusion criteria for conditions that can alter prolactin levels of all studies dealing with the addition of dopamine agonists to lower prolactin.
Reference | Diagnostic criteria for psychotic disorders | Exclusion criteria (reproductive or medical conditions that can alter prolactin levels)† |
---|---|---|
Cabergoline addition | ||
Kalkavoura et al., 2013 | DSM-IV | medication implicated in the increase of PRL levels (tricyclic antidepressants, selective serotonin reuptake inhibitor, monoamine oxidase, a-methyldopa, estrogens, oral contraceptives), patients receiving medication implicated in sexual dysfunction (antihypertensives, diuretics, hormones, antifungoral therapy, Parkinson's disease), patients with hyperprolactinaemia due to pregnancy or breastfeeding, hypothyroidism, Cushing's syndrome, cirrhosis, renal failure, meningioma, craniopharyngioma, sarcoidosis, autoimmune disease, tumors of the hypothalamus, acromegalic dysplasia, prolactinoma, diabetes mellitus |
Coronas et al., 2012 | DSM-IV | NR |
Cavallaro et al., 2004 | DSM-IV | NR |
Bromocriptine addition | ||
Yuan et al., 2008 | ICD-10 | NR |
Bliesener et al., 2004 | NR | NR§ |
Terguride addition | ||
Hashimoto et al., 2014 | DSM-IV | NR |
Abbreviations: DSM-IV= Diagnostic and Statistical Manual of Mental Disorders – IV edition; ICD-10= International Classification of Diseases – 10th revision; NR= Not reported.
Information regarding substance use and exclusion criteria due to substance use disorders has been included in Table 5.
Although no exclusion criteria for medical condition were reported in the study, the authors specify that all patients had normal hepatic, renal and thyroid function.